Back to News
Market Impact: 0.18
Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development
Source: Business Wire
Healthcare & BiotechProduct LaunchesTechnology & Innovation
IDT and Aldevron launched research-grade S.p. Cas9 mRNA in wild-type and SpyFi formats for CRISPR genome-editing research and development. The product introduction expands tools available to researchers, but the announcement provides no revenue, commercial adoption, or financial guidance metrics.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Companies promised AI gains— here's how the payoff showed up in earnings
- Fears over $828 billion AI capex spending spree help erase $1 trillion in market value
- Intel stock plunges 29%. Analysts urge caution on buying the dip
- How Ambani’s Jio became India’s second-largest company
- From Karl Marx’s vampire to Warren Buffett’s moat, the crumbling gothic castle has been capitalism’s favorite metaphor for 250 years
- Anthropic's path to the Nasdaq just got a lot bumpier
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Which AI Investment Research Platforms Are SOC 2 Certified?
- State of M&A and Private Markets, June 2026: A $4.9 Trillion Rebound, Underwritten on Money That Never Got Cheaper